Pathophysiology
The study underscores the critical role of the complement system, specifically C3, in innate immune defense against pathogens, suggesting that deficiencies in this system contribute to higher HAI rates in critically ill patients [PMID:40193179].
ICU patients exhibited low microbiota diversity and high levels of pathobionts, with piperacillin-tazobactam use further exacerbating dysbiosis and increasing CRPA colonization risk [PMID:30383203].
The most common carbapenemase genes identified were blaOXA-23/51 in A. baumannii and blaNDM in K. pneumoniae, indicating their importance in the resistance mechanisms [PMID:29891594].
[PMID:29522559] Once colonized in the digestive mucosa or skin, Pseudomonas aeruginosa can lead to infections in immunocompromised patients, especially when there are breaches in mucosal or skin barriers caused by invasive devices.
Among the pathogens identified, Acinetobacter baumannii was the most prevalent, accounting for 31% of infections [PMID:40856805].
The study by Hällgren et al. [PMID:16138424] demonstrated an early shift towards Gram-positive bacteria dominance, specifically noting the emergence of resistant Enterococcus faecium clones, underscoring the dynamics of gut microbiota in critical care environments.
The study identified Staphylococcus aureus (68% methicillin-resistant) and Pseudomonas aeruginosa (76% antibiotic-resistant) as prevalent pathogens, highlighting the challenge of antimicrobial resistance in ICU settings [PMID:12392904].
Epidemiology
In Ethiopia, a low-income nation, ICU mortality rates due to nosocomial infections range from about 38.7% to 50.4% 4. A study at Jimma University Medical Center reported an overall ICU mortality rate of 50.4% in 2011–2012 9. [PMID:41462128]
Studies indicate that ICU-acquired nosocomial infections can have incidence rates as high as 54%, with mortality rates ranging from 25% to over 45% 5. [PMID:41462128]
This retrospective case-control study in ICU patients found that complement C3 levels correlate with the development of HAIs, highlighting the importance of immune markers in predicting infection risk [PMID:40193179].
The study observed no overall change in multidrug-resistant bacteria incidence, except for a notable decrease in Klebsiella pneumoniae with extended beta-lactamase and an increase in vancomycin-resistant Enterococcus faecium [PMID:35953676].
The study highlights that in ICU settings within a university-affiliated hospital in the Republic of Korea, where MRSA prevalence was 66-72% and VRE (specifically VREF) was 29-31% from 2013 to 2015, concurrent colonization with VRE and MRSA poses significant clinical risks [PMID:31601221].
Piperacillin-tazobactam use was more frequent in patients who acquired CRPA colonization [PMID:30383203], highlighting a potential risk factor within ICU settings.
The study found that hospitalization within the previous 6 months was a significant risk factor for CR-GNB colonization at ICU admission (P = 0.002) [PMID:29891594].
During ICU stays, 25.2% (52/206) of patients acquired CR-GNB, with Acinetobacter baumannii and Klebsiella pneumoniae being the predominant species [PMID:29891594].
[PMID:29522559] In 2012, 23% of ICU patients acquired healthcare-associated infections, with Pseudomonas aeruginosa being a notable pathogen due to its association with severe infections like ventilator-associated pneumonia and bacteremia.
Clinical Presentation
The study aimed to compare clinical outcomes between ICU patients co-colonized with VRE and MRSA versus those colonized solely with VRE, indicating a need for closer monitoring and potentially different management strategies for co-colonized patients [PMID:31601221].
Ventilator-associated pneumonia (VAP) accounted for 64% of nosocomial infections in the study, highlighting its prevalence in ICU settings [PMID:40856805].
Among those colonized, 240 patients (48.7%) progressed to CRB infections, highlighting the significant risk of infection following colonization [PMID:40205251].
Beyond VAP, ICU patients with elevated oral bacterial counts are also more likely to experience delirium, indicating a broader clinical impact on patient status [PMID:40017233].
Patients with EBV reactivation had fewer ventilator-free days at day 28 (18 [1-22] days vs. 21 days [5-26]) and a higher incidence of acute respiratory distress syndrome (34.3% vs. 17%) compared to those without reactivation [PMID:38436725].
While 18.8% showed clinical signs, nearly half (45.8%) had subclinical candidiasis, indicating silent infections are common [PMID:37114365].
Among 481 patients admitted to the ICU for over 48 hours without initial colonization, 52% (250 patients) acquired Gram-negative bacteria colonization during their stay [PMID:25493969].
The most frequently isolated microorganisms were nonfermentative gram-negative organisms and methicillin-resistant Staphylococcus aureus (MRSA) [PMID:15796288].
The study by Peña et al. [PMID:9032631] found that a higher clinical severity score at admission was significantly associated with ESBL-KP faecal colonization (P = 0.004).
The study found that patients with respiratory diseases were among those with a heightened risk of mortality due to nosocomial infections [PMID:8124975].
Intubated patients were found to be colonized more frequently by P. aeruginosa than those without intubation [PMID:7907624].
There was a strong correlation between low initial arterial pH values and upper respiratory tract colonization by P. aeruginosa [PMID:7907624].
The study identified mechanical ventilation as a significant risk factor for Xanthomonas maltophilia infection/colonization among ICU patients [PMID:1593100], suggesting a need for heightened vigilance in this patient subgroup.
Diagnosis
Participants in the study had immune markers, including C3 levels, assessed within 48 hours of admission, indicating potential utility in early risk stratification for HAIs [PMID:40193179].
Diagnostic approaches for ICU-acquired infections should incorporate spatio-temporal factors, recognizing that the timing and location of patient care within the ICU can influence infection risk [PMID:27586677].
The study utilized peri-rectal cultures collected at admission, weekly, and discharge to identify Pseudomonas aeruginosa colonization, providing a practical diagnostic approach [PMID:26832307].
Critically ill patients often present with systemic inflammatory response syndrome (SIRS) symptoms that can mimic infections caused by non-infectious etiologies, complicating timely and accurate diagnosis [PMID:23995121].
Clinical isolates from patients were compared to waterborne P. aeruginosa using multiplex-rep PCR, PFGE, and whole-genome sequencing, confirming the water network as the source for 4.09% of infections [PMID:38705477].
The study utilized a combination of clinical inspection for oral lesions and cytopathological examinations to diagnose clinical (with lesions) and subclinical (without lesions but positive cytology) forms of candidiasis [PMID:37114365].
While direct plating on Chromogenic UTI medium was effective for Gram-negative bacteria, enrichment broths were crucial for accurately detecting resistant Gram-positive bacteria like Enterococcus faecium [PMID:16138424].
Only 5% (3/60) of patients colonized with CAZ-RGN had the organism detected in clinical cultures, underscoring the necessity of surveillance cultures for accurate detection [PMID:10397210].
Differential Diagnosis
Given the potential for VRE to transfer resistance genes like vanA to MRSA, clinicians should consider co-colonization as a differential diagnosis in ICU patients experiencing recurrent or persistent infections, especially in high MRSA prevalence settings [PMID:31601221].
Higher abundance of protective taxa like Clostridiales at ICU admission was associated with a lower risk of CRPA colonization acquisition [PMID:30383203].
The TLR9-T1237C polymorphism was associated with a lower incidence and fewer relapses of central nervous system infections and urinary tract infections compared to patients with mixed TLR4 polymorphisms [PMID:29860039].
The study emphasizes the importance of monitoring colonization status, as it can precede clinical infections and influence patient outcomes [PMID:26173689].
The study highlights the importance of differentiating colonization from infection, as antibiotic use is prevalent among both colonized and non-colonized patients, suggesting a need for careful monitoring and diagnostic criteria [PMID:25493969].
Genotyping using pulsed-field gel electrophoresis identified common genotypes among patients, aiding in distinguishing between potential endogenous and exogenous sources of Pseudomonas aeruginosa infections [PMID:12660124].
Management
Studies show that implementing effective prevention and control measures can reduce mortality due to NIs 1718. Key strategies include national hospital infection-prevention policies, monitoring infection rates, and enhancing healthcare professionals’ awareness 19. [PMID:41462128]
Identifying patients with low C3 levels early could inform targeted interventions beyond standard antibiotic therapy to mitigate the risk of HAIs [PMID:40193179].
In this case-control study over 5 years, selective oral decontamination was linked to less frequent occurrences of ventilator-associated pneumonia and ICU deaths [PMID:35953676].
The research underscores the importance of implementing active surveillance cultures for both VRE and MRSA, particularly at ICU admission and weekly thereafter, to detect co-colonization early and implement appropriate infection control measures [PMID:31601221].
Piperacillin-tazobactam was linked to decreased abundance of protective gut bacteria like Lactobacillus and Clostridiales, increasing the risk of CRPA colonization [PMID:30383203].
Risk factors for acquiring CR-GNB during ICU stays included the use of an enteral feeding tube (P = 0.008), and the administration of third-generation cephalosporins (P = 0.032) and carbapenems (P = 0.045) [PMID:29891594].
[PMID:29522559] The study emphasizes the importance of considering the interaction between environmental factors and antibiotic selective pressure in developing strategies to prevent Pseudomonas aeruginosa colonization and infection.
Effective management of ICU-acquired infections requires accounting for temporal variations in environmental and preventive factors through calendar time analysis, alongside individual patient risk factors like duration of ICU stay [PMID:27586677].
Understanding colonization status can guide more precise empiric antibiotic choices, balancing between broad-spectrum coverage and targeted therapy to prevent resistance emergence [PMID:26832307].
This retrospective study in a pediatric ICU found that the use of SPN compared to exclusive enteral nutrition (EN) warrants further exploration for its impact on nosocomial infection rates, with conflicting evidence suggesting potential benefits or risks [PMID:26443996].
The research underscores the need to investigate whether early versus late initiation of SPN influences nosocomial infection incidence, given the importance of timing in clinical outcomes [PMID:26443996].
The paper discusses the risks associated with aggressive early antibiotic initiation, including increased antimicrobial resistance and potential side effects, suggesting that delaying antibiotic therapy until a more accurate diagnosis is made can be a safer strategy without significantly impacting patient outcomes [PMID:23995121].
A Cochrane review cited in the paper indicates that delaying antibiotic prescription can decrease antibiotic consumption by 32% without significantly impacting patient outcomes, particularly for respiratory infections, suggesting a potential adaptation for ICU settings [PMID:23995121].
Prophylactic regimens like SDD and SOD, which involve antimicrobial interventions in the oropharynx and gastrointestinal tract, have been shown to decrease respiratory tract infections (RTI) and improve survival in ICU patients [PMID:19551370]. However, discontinuation of these interventions at ICU discharge may increase the risk of HAI in the subsequent 14 days.
The research underscores the importance of close monitoring for HAIs, including RTIs, in the first two weeks post-ICU discharge for patients who received SDD or SOD, given the observed increased risk during this period [PMID:19551370].
The study underscores the importance of routine surveillance cultures for early detection of CRB colonization, which can inform targeted preventive measures [PMID:40205251].
Given the high prevalence and identified risk factors, implementing targeted screening protocols for MDR-GNB at ICU admission based on these factors (such as length of stay and antibiotic history) is crucial for effective infection control [PMID:39463102].
The study highlights that even with antimicrobial filters installed at all water points-of-use, the risk of P. aeruginosa contamination persisted, suggesting the need for additional preventive measures beyond filtration [PMID:38705477].
A significantly higher proportion of patients with EBV reactivation required renal replacement therapy (30% vs. 11.9%) compared to those without reactivation [PMID:38436725].
Complications
NIs are linked to poor outcomes including prolonged ICU and hospital stays, increased hospitalization expenses, and higher mortality rates 1011. [PMID:41462128]
Despite benefits, the study highlighted a potential ecological impact of SOD, including a higher rate of vancomycin-resistant Enterococcus faecium emergence [PMID:35953676].
CRPA colonization acquisition in ICU patients, influenced by factors like antibiotic use and gut microbiota composition, increases the risk of developing CRPA infections [PMID:30383203].
Previous studies cited in the paper indicate that PN approaches, even when used in combination with EN as SPN, often result in higher infectious complications compared to exclusive enteral nutrition [PMID:26443996].
The review points out that aggressive empiric antibiotic therapy, while potentially beneficial for survival, poses risks such as promoting antimicrobial resistance and selecting for opportunistic pathogens like Clostridium difficile [PMID:23995121].
The research highlights that after ICU discharge, patients previously treated with SDD or SOD face a notable risk of developing HAIs, particularly RTIs, possibly due to changes in their microbial ecology post-intervention cessation [PMID:19551370].
EBV reactivation was associated with increased rates of infections (92.9% vs. 78%) and septic shock (58.6% vs. 32.2%) among ICU patients [PMID:38436725].
Patients with infections from antibiotic-resistant bacteria experienced a 15% increase in excess length of stay, indicating prolonged ICU stays and potential complications [PMID:34657648].
The study [PMID:31938829] highlighted that while pantoprazole effectively reduced the risk of clinically important gastrointestinal bleeding (CIB) without heterogeneity, there were indications of increased risks of serious adverse events in more severely ill patients.
The study found that colonization with MDR-GNB or ESBL upon admission was linked to increased ICU mortality [PMID:27130993].
The study found that IAI was associated with prolonged ICU stay, increased nursing workload, and higher ICU and hospital mortality rates in both elderly and younger patients [PMID:24856114].
The study found a significant association between infections by resistant microorganisms and patient mortality, emphasizing the critical need for effective infection control measures to mitigate mortality risks [PMID:21340281].
Prognosis & Follow-up
Among patients studied, those colonized with Pseudomonas aeruginosa at ICU admission had a higher incidence of clinical cultures positive for the same strain later, indicating a potential prognostic implication [PMID:26832307].
The study found that the relative risk reduction in ICU mortality associated with SDD decreased from 35% during ICU stay to 22% at hospital discharge, suggesting a potential link to higher HAI rates post-discharge [PMID:19551370].
The median ICU stay for patients who developed nosocomial infections was 16 days, suggesting a correlation between prolonged ICU stays and infection risk [PMID:40856805].
CRB-infected patients exhibited significantly higher mortality rates (p = 0.006) compared to those without CRB infections [PMID:40205251].
Although there was no significant difference in 90-day mortality rates between patients with and without EBV reactivation (25.7% vs. 15.3%), reactivation was linked to higher morbidity and worse clinical outcomes [PMID:38436725].
Outcome measures showed a significant association between the presence of oral candidiasis and patient prognosis, suggesting it may impact recovery [PMID:37114365].
Mortality rates were evaluated three weeks after the study days, suggesting that ICU-acquired infections significantly impact patient survival [PMID:18437845].
Haemodynamic stabilization and optimization of tissue oxygenation are vital strategies that can save lives in patients with nosocomial infections [PMID:17944969].
[PMID:12898002] Median length of ICU stay was significantly longer for patients with nosocomial infections (13 days) compared to those without (2 days).
Despite the high incidence of various infections, the study found no association between ICU-acquired infections and increased risk of death [PMID:12392904].
The study [PMID:9032631] noted that the probability of remaining free from ESBL-KP faecal colonization was less than 20% by 30 days of ICU admission, indicating a progressive increase in risk over time.
Special Populations
The study emphasizes that ICU patients, especially those with compromised immune systems, are at significantly higher risk for HAIs, with C3 levels serving as a potential indicator of this vulnerability [PMID:40193179].
Despite representing 18.9% of the ICU population, elderly patients had similar rates of invasive mechanical ventilation, central venous catheterization, and renal replacement therapy as younger patients, with comparable mean organ dysfunction scores at admission [PMID:24856114].
The vulnerability of ICU patients to nosocomial infections stems from their complex underlying diseases and the use of invasive devices, highlighting the need for tailored infection control strategies [PMID:7962982].
Key Recommendations
The research suggests that while SOD can reduce ventilator-associated pneumonia and ICU mortality, continuous surveillance for specific resistant bacteria is crucial [PMID:35953676]. (Evidence: Moderate)
The paper discusses conflicting recommendations regarding SPN, noting that while some studies suggest potential benefits in reducing nosocomial infections, others advise against combining PN with EN due to increased infection risks [PMID:26443996]. (Evidence: Weak)
The paper highlights that while delayed antibiotic therapy can reduce unnecessary use, it significantly lowers patient satisfaction compared to immediate treatment, emphasizing the need for thorough patient education [PMID:23995121]. (Evidence: Moderate)
Given the findings, the authors recommend conducting regular microbiological surveys of filtered water in ICUs at risk for P. aeruginosa infections, even when equipped with antimicrobial filters [PMID:38705477]. (Evidence: Expert opinion)
Given the observed heterogeneity in treatment effects [PMID:31938829], current guidelines may benefit from prospective investigations to tailor acid suppression therapy more precisely to patient-specific risk profiles. (Evidence: Expert opinion)
The study supports the suggestion of universal screening for MRSA, ESBL, and MDR-GNB upon admission to identify high-risk patients and potentially mitigate adverse outcomes [PMID:27130993]. (Evidence: Expert opinion)
Despite observed benefits, the authors emphasize the need for more robust studies to thoroughly explore the effects of these interventions [PMID:25579286]. (Evidence: Expert opinion)
Given the strong link between resistant microorganisms and mortality, the research underscores the necessity for rigorous monitoring and adherence to infection control protocols in ICU settings to enhance patient outcomes [PMID:21340281]. (Evidence: Expert opinion)
[PMID:20191192] Given the predominance of comorbidities as risk factors, the study recommends focusing preventive efforts on patients with solid malignancies, AIDS, central nervous system diseases, and those requiring central venous catheters. (Evidence: Expert opinion)
The study concluded that routine surveillance for HAIs, coupled with revised infection prevention measures and antimicrobial therapy policies, led to a reduction in both HAIs and mortality [PMID:15796288]. (Evidence: Strong)
Patients with high risk scores from a predictive model of nosocomial infection should be prioritized for specialized preventive interventions [PMID:9442407]. (Evidence: Strong)
Given that younger and less severely ill patients face a disproportionately higher risk of mortality from nosocomial infections, stringent infection control protocols are recommended [PMID:8124975]. (Evidence: Expert opinion)
References
1 Shacho E, Yilma D, Goshu AT, Ambelu A. Adult intensive care unit nosocomial infections related deaths in Jimma medical center: a cause specific cox regression analysis. BMC infectious diseases 2025. link 2 Wang C, Chen B, Ying Z, Shen M, Luo Y, Lin T et al.. Impact of complement C3 levels on the development of healthcare-associated infections in intensive care patients: a retrospective case-control study. Annals of medicine 2025. link 3 Wang B, Briegel J, Krueger WA, Draenert R, Jung J, Weber A et al.. Ecological effects of selective oral decontamination on multidrug-resistance bacteria acquired in the intensive care unit: a case-control study over 5 years. Intensive care medicine 2022. link 4 Yoon YK, Lee MJ, Ju Y, Lee SE, Yang KS, Sohn JW et al.. Determining the clinical significance of co-colonization of vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in the intestinal tracts of patients in intensive care units: a case-control study. Annals of clinical microbiology and antimicrobials 2019. link 5 Pettigrew MM, Gent JF, Kong Y, Halpin AL, Pineles L, Harris AD et al.. Gastrointestinal Microbiota Disruption and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019. link 6 Kiddee A, Assawatheptawee K, Na-Udom A, Treebupachatsakul P, Wangteeraprasert A, Walsh TR et al.. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand. Antimicrobial agents and chemotherapy 2018. link 7 Hoang S, Georget A, Asselineau J, Venier AG, Leroyer C, Rogues AM et al.. Risk factors for colonization and infection by Pseudomonas aeruginosa in patients hospitalized in intensive care units in France. PloS one 2018. link 8 Wolkewitz M, Cooper BS, Palomar-Martinez M, Alvarez-Lerma F, Olaechea-Astigarraga P, Barnett AG et al.. Multiple time scales in modeling the incidence of infections acquired in intensive care units. BMC medical research methodology 2016. link 9 Harris AD, Jackson SS, Robinson G, Pineles L, Leekha S, Thom KA et al.. Pseudomonas aeruginosa Colonization in the Intensive Care Unit: Prevalence, Risk Factors, and Clinical Outcomes. Infection control and hospital epidemiology 2016. link 10 Wang D, Lai X, Liu C, Xiong Y, Zhang X. Influence of supplemental parenteral nutrition approach on nosocomial infection in pediatric intensive care unit of Emergency Department: a retrospective study. Nutrition journal 2015. link 11 Hranjec T, Sawyer RG. Conservative initiation of antimicrobial treatment in ICU patients with suspected ICU-acquired infection: more haste less speed. Current opinion in critical care 2013. link 12 de Smet AM, Hopmans TE, Minderhoud AL, Blok HE, Gossink-Franssen A, Bernards AT et al.. Decontamination of the digestive tract and oropharynx: hospital acquired infections after discharge from the intensive care unit. Intensive care medicine 2009. link 13 Ali WI, Hakeem LA, Mohammed ZT, Fawzi HA. Incidence of nosocomial infection in the intensive care unit of Ghazi Al-Hariri teaching hospital. Wiener klinische Wochenschrift 2026. link 14 Şahin S, Öcal GA, Bombacı E, Tekol SD. Intensive care unit-acquired rectal colonization and subsequent infections with carbapenem-resistant bacteria: a cross-sectional study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2025. link 15 Arimizu C, Akahoshi T, Jinno T, Furuta M, Ohashi A, Takamori S et al.. Association of Number of Oral bacteria with Ventilator-Associated Pneumonia and Delirium in Patients in the Intensive Care Unit. Journal of intensive care medicine 2025. link 16 Sania N, Saharman YR, Lestari DC, Aditianingsih D, Yasmon A. Risk Factors Associated with the Colonization of Multidrug-Resistant Gram-Negative Bacteria Upon Admission to the Intensive Care Unit: A Cross-sectional Study. Acta medica Indonesiana 2024. link 17 Royer G, Virieux-Petit M, Aujoulat F, Hersent C, Baranovsky S, Hammer-Dedet F et al.. Residual risk of Pseudomonas aeruginosa waterborne contamination in an intensive care unit despite the presence of filters at all water points-of-use. The Journal of hospital infection 2024. link 18 Guiouillier F, Derely J, Salvadori A, Pochard J, Le Goff J, Martinez T et al.. Reactivation of Epstein-Barr virus among intensive care patients: a prospective observational study. Intensive care medicine 2024. link 19 Dos Santos Freire FM, Marques LC, da Silva NC, Cunha KS, Conde DC, Milagres A et al.. Oral candidiasis in patients hospitalised in the intensive care unit: Diagnosis through clinical and cytopathological examinations. Cytopathology : official journal of the British Society for Clinical Cytology 2023. link 20 Serra-Burriel M, Campillo-Artero C, Agodi A, Barchitta M, López-Casasnovas G. Association between antibiotic resistance in intensive care unit (ICU)-acquired infections and excess resource utilization: Evidence from Spain, Italy, and Portugal. Infection control and hospital epidemiology 2022. link 21 Granholm A, Marker S, Krag M, Zampieri FG, Thorsen-Meyer HC, Kaas-Hansen BS et al.. Heterogeneity of treatment effect of prophylactic pantoprazole in adult ICU patients: a post hoc analysis of the SUP-ICU trial. Intensive care medicine 2020. link 22 Chatzi M, Papanikolaou J, Makris D, Papathanasiou I, Tsezou A, Karvouniaris M et al.. Toll-like receptor 2, 4 and 9 polymorphisms and their association with ICU-acquired infections in Central Greece. Journal of critical care 2018. link 23 Fouda R, Soliman MS, ElAnany MG, Abadeer M, Soliman G. Prevalence and risk factors of MRSA, ESBL and MDR bacterial colonization upon admission to an Egyptian medical ICU. Journal of infection in developing countries 2016. link 24 Papadimitriou-Olivgeris M, Spiliopoulou I, Christofidou M, Logothetis D, Manolopoulou P, Dodou V et al.. Co-colonization by multidrug-resistant bacteria in two Greek intensive care units. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2015. link 25 Zaky A, Zeliadt SB, Treggiari MM. Patient-level interventions to prevent the acquisition of resistant gram-negative bacteria in critically ill patients: a systematic review. Anaesthesia and intensive care 2015. link 26 Jongerden IP, Speelberg B, Satizábal CL, Buiting AG, Leverstein-van Hall MA, Kesecioglu J et al.. The role of systemic antibiotics in acquiring respiratory tract colonization with gram-negative bacteria in intensive care patients: a nested cohort study. Critical care medicine 2015. link 27 Maillet JM, Guérot E, Novara A, Le Guen J, Lahjibi-Paulet H, Kac G et al.. Comparison of intensive-care-unit-acquired infections and their outcomes among patients over and under 80 years of age. The Journal of hospital infection 2014. link 28 de Oliveira AC, Silva RS, Díaz ME, Iquiapaza RA. Bacterial resistance and mortality in an intensive care unit. Revista latino-americana de enfermagem 2010. link 29 Fortaleza CM, Figueiredo LC, Beraldo CC, Melo EC, Póla PM, Aragão VD. Risk factors of oropharyngeal carriage of Pseudomonas aeruginosa among patients from a Medical-Surgical Intensive Care Unit. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2009. link 30 De Rosa FG, Garazzino S, Audagnotto S, Bargiacchi O, Zeme DA, Gramoni A et al.. SPIR01 and SPIR02: a two-year 1-day point prevalence multicenter study of infections in intensive care units in Piedmont, Italy. The new microbiologica 2008. link 31 Blot S. Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2008. link 32 Hällgren A, Burman LG, Isaksson B, Olsson-Liljeqvist B, Nilsson LE, Saeedi B et al.. Rectal colonization and frequency of enterococcal cross-transmission among prolonged-stay patients in two Swedish intensive care units. Scandinavian journal of infectious diseases 2005. link 33 Orsi GB, Raponi M, Franchi C, Rocco M, Mancini C, Venditti M. Surveillance and infection control in an intensive care unit. Infection control and hospital epidemiology 2005. link 34 Erbay H, Yalcin AN, Serin S, Turgut H, Tomatir E, Cetin B et al.. Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey. Intensive care medicine 2003. link 35 Thuong M, Arvaniti K, Ruimy R, de la Salmonière P, Scanvic-Hameg A, Lucet JC et al.. Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an intensive care unit. The Journal of hospital infection 2003. link 36 Urli T, Perone G, Acquarolo A, Zappa S, Antonini B, Ciani A. Surveillance of infections acquired in intensive care: usefulness in clinical practice. The Journal of hospital infection 2002. link 37 D'Agata EM, Venkataraman L, DeGirolami P, Burke P, Eliopoulos GM, Karchmer AW et al.. Colonization with broad-spectrum cephalosporin-resistant gram-negative bacilli in intensive care units during a nonoutbreak period: prevalence, risk factors, and rate of infection. Critical care medicine 1999. link 38 Fernández-Crehuet R, Díaz-Molina C, de Irala J, Martínez-Concha D, Salcedo-Leal I, Masa-Calles J. Nosocomial infection in an intensive-care unit: identification of risk factors. Infection control and hospital epidemiology 1997. link 39 Peña C, Pujol M, Ricart A, Ardanuy C, Ayats J, Liñares J et al.. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit. The Journal of hospital infection 1997. link90163-8) 40 Bueno-Cavanillas A, Delgado-Rodríguez M, López-Luque A, Schaffino-Cano S, Gálvez-Vargas R. Influence of nosocomial infection on mortality rate in an intensive care unit. Critical care medicine 1994. link 41 Trilla A. Epidemiology of nosocomial infections in adult intensive care units. Intensive care medicine 1994. link 42 Ismaeel NA. Colonization of intensive care unit patients by Pseudomonas aeruginosa. The Journal of hospital infection 1993. link90114-f) 43 Villarino ME, Stevens LE, Schable B, Mayers G, Miller JM, Burke JP et al.. Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients. Infection control and hospital epidemiology 1992. link
43 papers cited of 49 indexed.